Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-23-073048
Filing Date
2023-06-21
Accepted
2023-06-20 20:56:55
Documents
1
Group Members
DR. JAMES I. HEALYDR. MAHA KATABISOFINNOVA MANAGEMENT X, L.P.SOFINNOVA MANAGEMENT X-A, L .L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2319284d2_sc13da.htm SC 13D/A 130804
  Complete submission text file 0001104659-23-073048.txt   132427
Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners X, L.P. (Filed by) CIK: 0001680200 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Subject) CIK: 0001771917 (see all company filings)

EIN.: 270605902 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91054 | Film No.: 231027192
SIC: 2834 Pharmaceutical Preparations